Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1.
Scientific Reports
Chasman, Daniel I DI; Hyde, Craig L CL; Giulianini, Franco F; Danning, Rebecca D RD; Wang, Ellen Q EQ; Hickling, Timothy T; Ridker, Paul M PM; Loomis, A Katrina AK
Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.
Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology
Neumeyer, Sonja S; Hua, Xinwei X; Seibold, Petra P; Jansen, Lina L; Benner, Axel A; Burwinkel, Barbara B; Halama, Niels N; Berndt, Sonja I SI; Phipps, Amanda I AI; Sakoda, Lori C LC; Schoen, Robert E RE; Slattery, Martha L ML; Chan, Andrew T AT; Gala, Manish M; Joshi, Amit D AD; Ogino, Shuji S; Song, Mingyang M; Herpel, Esther E; Bläker, Hendrik H; Kloor, Matthias M; Scherer, Dominique D; Ulrich, Alexis A; Ulrich, Cornelia M CM; Win, Aung K AK; Figueiredo, Jane C JC; Hopper, John L JL; Macrae, Finlay F; Milne, Roger L RL; Giles, Graham G GG; Buchanan, Daniel D DD; Peters, Ulrike U; Hoffmeister, Michael M; Brenner, Hermann H; Newcomb, Polly A PA; Chang-Claude, Jenny J
Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma.
Cancer Immunology, Immunotherapy : Cii
Wang, Wei W; Ollila, Hanna M HM; Whittemore, Alice S AS; Demehri, Shadmehr S; Ioannidis, Nilah M NM; Jorgenson, Eric E; Mignot, Emmanuel E; Asgari, Maryam M MM